tiprankstipranks
Trending News
More News >
Ars Pharmaceuticals, Inc. (SPRY)
NASDAQ:SPRY
US Market

ARS Pharmaceuticals (SPRY) Revenue

Compare
564 Followers

ARS Pharmaceuticals Revenue

ARS Pharmaceuticals had a revenue of 32.50M in the quarter ending Sep 30, 2025, with 106.79%. This bring the company's revenue in the last twelve months to 142.77M, Decreased 27.09%. In the fiscal year ending Dec 31, 2024, ARS Pharmaceuticals had annual revenue of 89.15M with 297063.33% growth.
Revenue (ttm)
142.77M
Revenue Growth
5459.66%
P/S Ratio
9.84
Revenue/Employee
$575,155
Employees
155
Market Cap
$876.79M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
89.15M89.12M+297,063.33%
Dec 31, 2023
30.00K-1.29M-97.72%
Dec 31, 2022
1.32M-4.19M-76.10%
Mar 31, 2022
5.51M-12.33M-69.13%
Dec 31, 2020
17.84M+∞%
Dec 31, 2019
Dec 31, 2018